Yes, technology has the potential to make healthcare more accessible, affordable, and convenient. BioEngine4D™ is one example of a platform that is using AI to analyze life data and create digital biomarkers for early disease detection and prediction. Smart devices like smartphones and smartwatches have sensors that can collect life data and make healthcare more accessible.
Smart devices like smartphones have multimodal sensors that may be able to detect diseases through data collected in everyday life. BioTrillion is working on a health technology platform called BioEngine4D™ that uses AI to analyze life data and generate digital biomarkers for early disease detection and prediction. This can make healthcare more accessible, affordable, and convenient.
Smart devices like smartphones and smartwatches have sensors that can collect life data, such as environmental factors and disease expressions. This data can be processed using AI to detect or predict diseases through the creation of digital biomarkers. BioTrillion's BioEngine4D™ platform is using this approach to improve healthcare and make it more accessible, affordable, and convenient.
Risk factors are indicators of the likelihood of developing a disease in the future, while biomarkers are used to detect the presence of a disease. Life data, such as device-generated physiological and behavioral data, can be analyzed using AI to create digital biomarkers for early disease detection or prediction. BioTrillion is developing a mobile digital biomarker technology platform called BioEngine4D™ to improve healthcare in key areas.
Smartwatches can continuously measure heart rate, which can be analyzed using AI to detect cardiovascular abnormalities and serve as a digital biomarker. BioTrillion's BioEngine4D™ platform is using this approach to improve healthcare accessibility, affordability, and convenience. Digital biomarkers, like heart rate, offer advantages over molecular biomarkers as they can be measured frequently and at scale.
BioTrillion's platform, BioEngine4D™, uses AI to analyze life data and create digital biomarkers for early disease detection and prediction. This approach has the potential to make healthcare more accessible, affordable, and convenient. Traditional medical settings only provide data for about 1% of a person's time and often rely on expensive and invasive methods, like blood or tissue samples, to measure biomarkers. BioEngine4D™ is designed to continuously measure life data and generate digital biomarkers, which can be used to improve healthcare and make it more accessible, affordable, and convenient.
The benefits of BioTrillion's platform for healthcare include:
Traditional approaches to healthcare often rely on expensive and invasive methods, like blood or tissue samples, to measure molecular biomarkers. These methods only provide data for about 1% of a person's time and are not continuous. BioTrillion's platform, BioEngine4D™, uses AI to continuously measure life data and generate digital biomarkers for early disease detection and prediction. This approach has the potential to make healthcare more accessible, affordable, and convenient.
Technology has allowed us to observe macroscopic and microscopic dimensions, but there is valuable visual information at the "milli scale" that is not perceived or remembered by humans. This scale, which can be broken down into spatial millimeters or temporal milliseconds, contains life data that can be analyzed using AI to create digital biomarkers for early disease detection and prediction. BioTrillion's BioEngine4D™ platform focuses on unlocking these features for health insights.
There is a difference between seeing and perceiving. There is valuable visual information that occurs every day in front of our eyes that we "see" but do not "perceive" or remember. We have developed innovative technologies for both macro and micro visual scales, but what about the middle, the "milli scale" - the scale at which we can technically see, but usually do not perceive or remember? Many developing diseases express their features as life data in a dynamic pattern that can be better detected through more accessible and frequent anatomic and physiologic digital measures.
The milli scale can be further broken down by dimensions: space or time. We believe a treasure of health information remains trapped at the milli scale's features, particularly in the milli temporal dimension. We are on a mission to unlock these life data features into digital biomarkers for health insights.
Yes, and this presents an opportunity. In healthcare, the eyes and face are a classic example of the milli scale's potential, but there has been a lack of innovation in this area. For example, consider the human eye. There is spatial information that we can see, such as the millimeter size of a pupil or hand tremor frequency, that can provide insights into one's emotional state. There is also temporal information, such as the millisecond time it takes for a pupil to constrict when stimulated by light or hand movement time, that can provide insights into one's neurologic function. There is tremendous potential to innovate new technologies that can measure and produce insights from features in the world of millimeters and milliseconds. This is especially true considering the rapid pace of hardware advancements in smartphone cameras with annually improving resolutions and frame rates.
The smartphone in your pocket is only getting smarter and more powerful. This presents an opportunity to harness its capabilities for healthcare applications. BioTrillion's BioEngine4D™ platform is focused on unlocking the potential of the milli scale for health insights. Our goal is to use AI to create digital biomarkers that can detect and predict disease earlier than ever before. Join us in this mission to revolutionize healthcare.
The human body is the most complex machine ever engineered by evolution, but it is too complex, non-linear, and interconnected for the human brain to reverse engineer alone. We now need computers, human-engineered machines, to reverse engineer the body.
BioTrillion was designed from the start to achieve mass scale through synergies. Instead of starting with a disease and creating a device to measure its signs, BioTrillion starts with the signs of disease that 1 billion people can already measure today.
The rising costs and limited improvements in healthcare outcomes call for innovative solutions that focus on accessibility, affordability, continuity, timeliness, and data-driven outcomes. We aim to empower individuals with better disease detection solutions and accelerate the drug development process through technology.
Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception. After all, no one will have a greater interest in your health than you.